These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8734771)

  • 21. Prednisone as initial treatment of analgesic-induced daily headache.
    Krymchantowski AV; Barbosa JS
    Cephalalgia; 2000 Mar; 20(2):107-13. PubMed ID: 10961766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analgesic rebound headache in children and adolescents.
    Vasconcellos E; Piña-Garza JE; Millan EJ; Warner JS
    J Child Neurol; 1998 Sep; 13(9):443-7. PubMed ID: 9733291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of tizanidine and amitriptyline in the prophylaxis of chronic tension-type headache: evaluation of efficacy and impact on quality of life.
    Bettucci D; Testa L; Calzoni S; Mantegazza P; Viana M; Monaco F
    J Headache Pain; 2006 Feb; 7(1):34-6. PubMed ID: 16514501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug-induced headache and pain reduction medication with amitriptyline in an 11-year old pupil].
    Croissant B; Brosi K; Hermann D; Mann K
    Nervenarzt; 2004 May; 75(5):489-91. PubMed ID: 15282848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache.
    Diener HC; Haab J; Peters C; Ried S; Dichgans J; Pilgrim A
    Headache; 1991 Apr; 31(4):205-9. PubMed ID: 1646775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study.
    Krymchantowski AV; Silva MT; Barbosa JS; Alves LA
    Headache; 2002 Jun; 42(6):510-4. PubMed ID: 12167139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache.
    Trucco M; Meineri P; Ruiz L;
    J Headache Pain; 2005 Sep; 6(4):334-7. PubMed ID: 16362704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of spinal manipulation, amitriptyline and the combination of both therapies for the prophylaxis of migraine headache.
    Nelson CF; Bronfort G; Evans R; Boline P; Goldsmith C; Anderson AV
    J Manipulative Physiol Ther; 1998 Oct; 21(8):511-9. PubMed ID: 9798179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of chronic daily headache utilizing a uniform treatment pathway.
    Rothrock JF
    Headache; 1999 Oct; 39(9):650-3. PubMed ID: 11279960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacodynamics of sumatriptan in nitroglycerin-induced headache.
    Fullerton T; Komorowski-Swiatek D; Forrest A; Gengo FM
    J Clin Pharmacol; 1999 Jan; 39(1):17-29. PubMed ID: 9987697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ergotamine-induced headache can be sustained by sumatriptan daily intake.
    Catarci T; Fiacco F; Argentino C; Sette G; Cerbo R
    Cephalalgia; 1994 Oct; 14(5):374-5. PubMed ID: 7828198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy.
    Suhr B; Evers S; Bauer B; Gralow I; Grotemeyer KH; Husstedt IW
    Cephalalgia; 1999 Jan; 19(1):44-9. PubMed ID: 10099859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication overuse headache.
    Diener HC; Katsarava Z
    Curr Med Res Opin; 2001; 17 Suppl 1():s17-21. PubMed ID: 12463272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fluvoxamine, amitriptyline and transcranial electrostimulation of the brain in the treatment of chronic daily headache].
    Tarasova SV; Amelin AV; Skoromets AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):43-6. PubMed ID: 18577934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daily sumatriptan for detoxification from rebound.
    Drucker P; Tepper S
    Headache; 1998 Oct; 38(9):687-90. PubMed ID: 15613182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Headache medication-use among primary care headache patients in a health maintenance organization.
    Von Korff M; Black LK; Saunders K; Galer BS
    Cephalalgia; 1999 Jul; 19(6):575-80; discussion 541-2. PubMed ID: 10448544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration in nature of cluster headache during subcutaneous administration of sumatriptan.
    Hering-Hanit R
    Headache; 2000 Jan; 40(1):41-4. PubMed ID: 10759902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study.
    Evers S; Gralow I; Bauer B; Suhr B; Buchheister A; Husstedt IW; Ringelstein EB
    Clin Neuropharmacol; 1999; 22(4):201-6. PubMed ID: 10442248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone.
    Cleland PG; Barnes D; Elrington GM; Loizou LA; Rawes GD
    Eur Neurol; 1997; 38(1):31-8. PubMed ID: 9252796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.